BEST3 trial saves patient's life
3 July 2019
Taking part in a Cancer Prevention Trial led to an unexpected diagnosis for one Plymouth patient
At the CCP, Professor Stephen Duffy is continuing his exceptional research track record in cancer epidemiology, screening and policy.
His new publication reports the results of the TOMMY trial that tested the effectiveness of adding a 3D imaging technique to standard mammography.
A new HPV (human papilloma virus) vaccine that protects against 9 types of the virus – 7 of which cause most cases of cervical cancer – has now been fully tested in a trial co-organised by Professor Jack Cuzick.
The new vaccine offers significantly greater protection than the current vaccine, which protects against only two cancer-causing types of HPV.
CCP researcher among the most influential one per cent in the world
21 September 2015
Prestigious Travel Award for CCP Researcher
9 July 2015
NHSCSP Audit of invasive cervical cancer
16 March 2015